Fairfield Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-173
| Closed | -$4.58K | – | 157 |
|
|
2024
Q4 | $4.58K | Sell |
173
-167
| -49% | -$4.42K | ﹤0.01% | 226 |
|
|
2024
Q3 | $9.83K | Buy |
340
+5
| +1% | +$145 | ﹤0.01% | 225 |
|
|
2024
Q2 | $9.37K | Buy |
+335
| New | +$9.37K | ﹤0.01% | 217 |
|
|
2023
Q4 | $9.35K | Sell |
325
-1,056
| -76% | -$30.4K | ﹤0.01% | 244 |
|
|
2023
Q3 | $45.8K | Sell |
1,381
-1,048
| -43% | -$34.8K | 0.02% | 144 |
|
|
2023
Q2 | $89.1K | Sell |
2,429
-597
| -20% | -$21.9K | 0.04% | 103 |
|
|
2023
Q1 | $122K | Sell |
3,026
-75
| -2% | -$3.03K | 0.05% | 87 |
|
|
2022
Q4 | $159K | Buy |
3,101
+70
| +2% | +$3.59K | 0.07% | 73 |
|
|
2022
Q3 | $133K | Buy |
3,031
+749
| +33% | +$32.8K | 0.06% | 78 |
|
|
2022
Q2 | $120K | Buy |
2,282
+315
| +16% | +$16.5K | 0.06% | 80 |
|
|
2022
Q1 | $102K | Buy |
+1,967
| New | +$102K | 0.04% | 87 |
|